Search - tctmd.com

Displaying 281 - 300 of 492

Sort: Relevancy | Date

News Daily News

Final SPRINT Results Endorse Intensive BP Control

Todd Neale

May 25, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Conference News ACC 2021

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

Michael O'Riordan

May 18, 2021

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Shelley Wood

May 16, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Daily News

Finerenone Cuts CV Events in CKD Patients With Diabetes: FIGARO-DKD

Michael O'Riordan

May 11, 2021

News Conference News SCAI 2021

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

Michael O'Riordan

May 06, 2021

News Daily News

FDA Approves Dapagliflozin for CKD Patients

Michael O'Riordan

May 03, 2021

News Opinion CV Team Dispatch

May 2021 News Roundup

L.A. McKeown

May 01, 2021

News Conference News SCAI 2021

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Michael O'Riordan

April 28, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Daily News

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Michael O'Riordan

April 21, 2021

News Daily News

Highest-Risk Patients Gain the Most From Intensive BP Therapy

Todd Neale

April 20, 2021

News Opinion CV Team Dispatch

April 2021 News Roundup

L.A. McKeown

April 10, 2021

News Daily News

Mobile Tech May Boost CAD Secondary Prevention for Older Adults

L.A. McKeown

April 07, 2021

News Daily News

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Michael O'Riordan

April 02, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Daily News

Pills for Erectile Dysfunction Linked to Fewer CVD Deaths

Caitlin E. Cox

March 24, 2021

News Opinion CV Team Dispatch

March 2021 News Roundup

L.A. McKeown

March 01, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

Advertisement

Final SPRINT Results Endorse Intensive BP Control

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Finerenone Cuts CV Events in CKD Patients With Diabetes: FIGARO-DKD

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

FDA Approves Dapagliflozin for CKD Patients

May 2021 News Roundup

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Highest-Risk Patients Gain the Most From Intensive BP Therapy

April 2021 News Roundup

Mobile Tech May Boost CAD Secondary Prevention for Older Adults

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Roughly 80% of ESC Guideline Writers Have Financial COIs

Pills for Erectile Dysfunction Linked to Fewer CVD Deaths

March 2021 News Roundup

February 2021 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content